A potential role suggested for SIRT5, another member of the SIRT family, is by regulation of OXPHOS through enhancement of glutamine metabolism and as a potential therapeutic target in the AML cells which depend on SIRT5 for glutamine metabolism[137]. The gene discussed is SIRT5; the disease is acute myeloid leukemia.